Disclosure Of Interests In Other Entities [Text Block]

Mithra Pharmaceuticals S.A. - Filing #3183077

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
Disclosure of interests in other entities [text block]
Disclosure of interests in subsidiaries [text block]
Disclosure of subsidiaries [text block]
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Profit (loss), attributable to non-controlling interests
- EUR
- EUR
Current assets
145,863,000 EUR
99,389,000 EUR
Non-current assets
296,552,000 EUR
322,528,000 EUR
Current liabilities
130,431,000 EUR
95,793,000 EUR
Non-current liabilities
278,298,000 EUR
292,285,000 EUR
Revenue
66,997,000 EUR
22,668,000 EUR
Profit (loss)
59,620,000 EUR
59,620,000 EUR
116,875,000 EUR
116,875,000 EUR
Comprehensive income
- EUR
18,298,000 EUR
77,918,000 EUR
59,620,000 EUR
- EUR
17,300,000 EUR
- EUR
- EUR
134,175,000 EUR
116,875,000 EUR
Disclosure of interests in associates [text block]
Disclosure of associates [text block]
Associates
Disclosure of associates [abstract]
Disclosure of associates [line items]
Other comprehensive income
18,298,000 EUR
17,300,000 EUR
Disclosure of interests in joint arrangements [text block]
Disclosure of joint ventures [text block]
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents
28,285,000 EUR
32,872,000 EUR
138,675,000 EUR
Other current financial liabilities
15,959,000 EUR
15,829,000 EUR
Other non-current financial liabilities
74,210,000 EUR
102,675,000 EUR
Tax expense (income)
48,139,000 EUR
6,895,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.